Peripheral Neuropathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with Chemotherapy-Induced Peripheral Neuropathy (CIPN):
- People aged 18 or older who can independently move their big toe up and down on their own
- People who can read, understand, and complete questionnaires in English without help, and who have normal or corrected vision (such as wearing glasses or contact lenses)
- People who are between 3 and 6 months into starting chemotherapy and have been formally diagnosed with CIPN through a nerve conduction study (a test that measures how well nerves send signals)
For the Healthy Control group (people without CIPN):
- People aged 18 or older who can independently move their big toe up and down on their own
- People who can read, understand, and complete questionnaires in English without help, and who have normal or corrected vision (such as wearing glasses or contact lenses)
- People with no known health conditions that are associated with problems in movement, balance, or muscle strength, particularly in the legs and feet
Who may not be able to join:
For the CIPN group:
- People who have other health conditions known to be linked to nerve damage or peripheral neuropathy, including but not limited to diabetes, arthritis, high blood pressure, thyroid disease, or heart disease
- People who have toe shape or structural problems unrelated to CIPN, such as bunions, hammer toes, claw toes, webbed toes, or similar conditions (confirm with trial site for the full list)
- People who report any weakness or reduced function in their foot, ankle, or big toe caused by a past illness or surgery
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +1 (352) 273-9934
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Great Toe Strength; Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-Ntx); System Usability Scale (SUS) Questionnaire
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.